P.O. Romero, R.M. Pujol, M. Cravo, C.M. Montserrat, I.Q. Cuba, D.N. Rodríguez, P. Fernández-Caldas González, M.A. Cortés, A. Combalia, R.M. Rodríguez Núñez, R. Córdoba, R. Cabral, A. Núñez, I. Zeberio, R. Fernández-de-Misa, M.L. Velasco, E.M. Feijoo, X. Martín-Martitegui, F.J. Capote, J.F. Millán Cayetano, A.M. Villar
{"title":"A-198 莫干珠单抗在西班牙和葡萄牙的实际疗效:MIBERIC研究的第二次中期分析","authors":"P.O. Romero, R.M. Pujol, M. Cravo, C.M. Montserrat, I.Q. Cuba, D.N. Rodríguez, P. Fernández-Caldas González, M.A. Cortés, A. Combalia, R.M. Rodríguez Núñez, R. Córdoba, R. Cabral, A. Núñez, I. Zeberio, R. Fernández-de-Misa, M.L. Velasco, E.M. Feijoo, X. Martín-Martitegui, F.J. Capote, J.F. Millán Cayetano, A.M. Villar","doi":"10.1016/j.ejca.2024.114405","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114405"},"PeriodicalIF":7.6000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A-198 Real-world effectiveness of mogamulizumab in Spain and Portugal: Second interim analysis of the MIBERIC study\",\"authors\":\"P.O. Romero, R.M. Pujol, M. Cravo, C.M. Montserrat, I.Q. Cuba, D.N. Rodríguez, P. Fernández-Caldas González, M.A. Cortés, A. Combalia, R.M. Rodríguez Núñez, R. Córdoba, R. Cabral, A. Núñez, I. Zeberio, R. Fernández-de-Misa, M.L. Velasco, E.M. Feijoo, X. Martín-Martitegui, F.J. Capote, J.F. Millán Cayetano, A.M. Villar\",\"doi\":\"10.1016/j.ejca.2024.114405\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11980,\"journal\":{\"name\":\"European Journal of Cancer\",\"volume\":\"211 \",\"pages\":\"Article 114405\"},\"PeriodicalIF\":7.6000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0959804924011018\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0959804924011018","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
期刊介绍:
The European Journal of Cancer (EJC) serves as a comprehensive platform integrating preclinical, digital, translational, and clinical research across the spectrum of cancer. From epidemiology, carcinogenesis, and biology to groundbreaking innovations in cancer treatment and patient care, the journal covers a wide array of topics. We publish original research, reviews, previews, editorial comments, and correspondence, fostering dialogue and advancement in the fight against cancer. Join us in our mission to drive progress and improve outcomes in cancer research and patient care.